Novel Platelet Function Analyzer 200 Predicts Blood Transfusion After Elective Cardiac Surgery in Patients Suspended...

Area of Science:

• Cardiology
• Hematology
• Surgical Research

Background:

• The utility of platelet function tests in guiding cardiac surgery timing is not well-established.
• Limited research exists on the correlation between the Platelet Function Analyzer 200 (PFA-200) and post-cardiac surgery bleeding.
• Assessing platelet function is crucial for managing perioperative bleeding risks.

Purpose of the Study:

• To evaluate the predictive value of the PFA-200 for the necessity of blood transfusions following elective cardiac surgery.
• To investigate the relationship between preoperative PFA-200 closure time (CT) and postoperative blood transfusion requirements.

Main Methods:

• A cohort of 71 patients undergoing cardiac surgery, who were on aspirin and P2Y12 inhibitors, was studied.
• Platelet function was assessed using the PFA-200, measuring closure time (CT) after discontinuing antiplatelet medications.
• Preoperative PFA-200 CT values were statistically analyzed against the primary endpoint of postoperative blood transfusion.

Main Results:

• Seventeen patients (21.9%) required blood transfusion post-surgery.
• Patients who received transfusions had significantly higher preoperative PFA-200 CT values (147.24 ± 85.54 s) compared to those who did not (98.06 ± 61.59 s, P = .011).
• A PFA-200 CT > 106 s was identified as an independent predictor of postoperative transfusion (OR: 4.05, P = .026), with a transfusion incidence of 41.9% in this group versus 14.7% in the normal group (P = .012).

Conclusions:

• The PFA-200 demonstrates predictive value for identifying patients needing blood transfusion after elective cardiac surgery.
• This platelet function test shows promise in optimizing the timing of cardiac surgical procedures.
• Preoperative PFA-200 assessment can aid in risk stratification for transfusion in cardiac surgery patients.